The difference between the biological age of the retina, the light sensitive layers of nerve tissue at the back of the eye, and a person's real (chronological) age, is linked to their risk of death, ...

Experts explain how longer-lasting anti-VEGF injections reduce treatment burden and improve real-world vision outcomes in AMD ...

Real-world retina data shows how aflibercept 8 mg and faricimab extend anti-VEGF intervals, guiding treat-and-extend for AMD and DME. In “Real-World Treatment Strategies in Retinal Vascular Diseases,” ...

Please provide your email address to receive an email when new articles are posted on . Retinal diseases are a major cause of severe vision loss, with numbers constantly increasing due to the aging of ...

Learn why newer anti‑VEGF options extend treatment for wet AMD, DME and RVO, signaling a shift from VEGF-only to multitarget ...

To investigate practice patterns and clinical outcomes in the repair of uncomplicated rhegmatogenous retinal detachments (RRD) in a real-world setting over a 10-year period. We compared preferences ...

Please provide your email address to receive an email when new articles are posted on . RetinAI and Retina Consultants of America will develop an AI-insight driven database. The database will include ...

How a simple in-home diabetic eye exam led to vision-saving treatment for one health plan member by prioritizing ...